Haleon
Sign in to saveAlso known as Haleon plc
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Key facts
- Company.name
- Haleon plc
- Company.logo
- Haleon.svg
- Company.image
- Brooklands office block, 22 July 2012 (2) (cropped).jpg
- Company.image_caption
- Headquarters in Weybridge, UK
- Company.type
- Public limited company
- Company.ISIN
- GB00BMX86B70
- Company.area_served
- Worldwide
- Company.revenue
- £11,030 million (2025)
- Company.operating_income
- £2,412 million (2025)
- Company.net_income
- £1,680 million (2025)
- Company.assets
- £32,630 million (2025)
- Company.equity
- £16,484 million (2025)
- Company.num_employees
- 24,000 (2024)
- Company.subsid
- Haleon Pakistan
- Company.location
- Weybridge, England, United Kingdom
via Wikipedia infobox
Company
HLN, HLNCF- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- Exchange
- NYSE, OTC
- State of incorporation
- X0
- Entity type
- other
- Latest filing
- 6-K · 2026-06-01
via SEC EDGAR
Official website
Home - Haleon
We are a world-leading consumer health company with a clear purpose to deliver better everyday health with humanity.
haleon.com →Link to the official site · 3,065 chars · not written by Vinony
~3 min read
Encyclopedic overview
7 sectionsContents
- History
- Operations
- Brands
- Current
- Divested
- References
- External links
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange.
Excerpted from Wikipedia’s “Haleon” article, available under the CC BY-SA 4.0 licence.
Gallery (2)
Available in 11 languages
via Wikidata sitelinks · CC0